U.S. federal trademark · Serial No. 99908104
Medical devices for the treatment of solid tumor cancers which cause partial intratumoral cell lysis and which deliver direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis; Medical apparatus, namely, devices which cause partial intratumoral cell lysis and which permit infusion and injection for locally targeted administration at the site of partial intratumoral lysis of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof
Providing a website featuring information in the field of health and medicine; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis
Providing a website featuring information in the field of clinical trials; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.